We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boxed Warnings Required for Visicol, OsmoPrep Labels
Boxed Warnings Required for Visicol, OsmoPrep Labels
December 12, 2008
The FDA will require a boxed warning on Salix Pharmaceuticals’ Visicol and OsmoPrep labels because the products, used to prepare for colonoscopies, are associated with a risk of kidney injury called acute phosphate nephrology.